🔴 AXSM is trading 4% down today as investors take profits after a post-earnings rally

AXSM is trading at $234.97 (4% down) in pre-market, pulling back from a strong run following its Q1 2026 earnings and Auvelity-related optimism.

• The stock recently surged over 10% on Q1 2026 results and more than 15% following a patent settlement with Teva over Auvelity.
• Today’s move appears to be driven by profit-taking and consolidation rather than a reaction to fresh company-specific news.